Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $43,683 - $48,605
-209 Reduced 2.1%
9,753 $2.13 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $77,494 - $89,097
392 Added 4.1%
9,962 $2.26 Million
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $65,944 - $72,717
328 Added 3.55%
9,570 $1.92 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $25,007 - $28,476
-118 Reduced 1.26%
9,242 $2.23 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $105,380 - $127,368
-494 Reduced 5.01%
9,360 $2.15 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $97,378 - $119,007
-478 Reduced 4.63%
9,854 $2.32 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $65,744 - $84,162
321 Added 3.21%
10,332 $2.12 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $43,627 - $56,685
-204 Reduced 2.0%
10,011 $2.35 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $47,027 - $53,970
181 Added 1.8%
10,215 $2.69 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $38,024 - $43,989
140 Added 1.41%
10,034 $3.15 Million
Q3 2021

Nov 10, 2021

BUY
$274.82 - $308.34 $109,103 - $122,410
397 Added 4.18%
9,894 $2.79 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $38,787 - $42,833
-154 Reduced 1.6%
9,497 $2.62 Million
Q1 2021

May 11, 2021

SELL
$204.88 - $255.03 $48,146 - $59,932
-235 Reduced 2.38%
9,651 $2.46 Million
Q4 2020

Feb 08, 2021

SELL
$186.91 - $214.42 $10,093 - $11,578
-54 Reduced 0.54%
9,886 $2.01 Million
Q3 2020

Oct 20, 2020

BUY
$167.03 - $201.3 $33,740 - $40,662
202 Added 2.07%
9,940 $1.87 Million
Q2 2020

Jul 27, 2020

BUY
$113.31 - $182.44 $76,257 - $122,782
673 Added 7.42%
9,738 $1.62 Million
Q1 2020

May 05, 2020

BUY
$104.32 - $195.28 $22,533 - $42,180
216 Added 2.44%
9,065 $1.15 Million
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $13,078 - $13,888
-80 Reduced 0.9%
8,849 $1.5 Million
Q3 2019

Nov 14, 2019

BUY
$159.77 - $178.1 $62,789 - $69,993
393 Added 4.6%
8,929 $1.5 Million
Q2 2019

Aug 07, 2019

SELL
$144.16 - $172.9 $80,585 - $96,651
-559 Reduced 6.15%
8,536 $1.48 Million
Q1 2019

May 03, 2019

BUY
$123.7 - $156.3 $41,810 - $52,829
338 Added 3.86%
9,095 $1.39 Million
Q4 2018

Feb 06, 2019

SELL
$120.82 - $174.09 $34,071 - $49,093
-282 Reduced 3.12%
8,757 $1.11 Million
Q3 2018

Oct 30, 2018

BUY
$167.67 - $188.27 $45,270 - $50,832
270 Added 3.08%
9,039 $1.57 Million
Q2 2018

Aug 08, 2018

BUY
$160.33 - $189.41 $94,274 - $111,373
588 Added 7.19%
8,769 $1.57 Million
Q1 2018

May 14, 2018

BUY
$161.53 - $178.11 $25,037 - $27,607
155 Added 1.93%
8,181 $1.32 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $1.19 Million - $1.32 Million
8,026
8,026 $1.28 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.